Loading stock data...

Centenial Surgical Suture Limited

BSE: CSURGSU

BSE
110.30 3.50 (3.28%)

Prev Close

106.8

Open Price

112.7

Volume

9

Today Low / High

110.3 / 112.7

52 WK Low / High

82.15 / 189

Range

105 - 116

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 110.3, reflecting a change of 3.5 (3.27715%). The expected target range on the BSE is 105 - 116. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

01 Oct 106.75 3.33%
30 Sep 106.80 0.00%
29 Sep 105.80 2.08%
26 Sep 104.80 0.10%
25 Sep 106.80 -1.78%
24 Sep 108.00 -3.33%
23 Sep 105.50 4.12%
22 Sep 105.50 0.00%
19 Sep 105.50 -1.18%
18 Sep 105.30 -0.90%
17 Sep 112.00 -2.41%
16 Sep 105.90 0.76%
15 Sep 103.40 1.55%
12 Sep 105.60 -1.33%
11 Sep 113.85 -7.69%
10 Sep 110.70 -2.44%
09 Sep 107.80 2.83%
08 Sep 107.80 0.00%
05 Sep 110.80 -5.23%
04 Sep 102.40 8.25%

Centenial Surgical Suture Limited Graph

Centenial Surgical Suture Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Centenial Surgical Suture Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 110.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 110.30 111.40 100.26 - 122.54
112.51 90.00 - 135.01
113.61 79.53 - 147.69
Bearish Scenario 110.30 109.20 98.28 - 120.12
108.09 86.48 - 129.71
106.99 74.89 - 139.09

Overview of Centenial Surgical Suture Limited

ISIN

INE405H01018

Industry

Medical - Specialties

Vol.Avg

470

Market Cap

402,407,490

Last Dividend

0

Official Website

Visit Website

IPO Date

2007-12-18

DCF Diff

46.74

DCF

64

Financial Ratios Every Investor Needs

Stock Rating Details for CSURGSU

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 53.52 Cr 33.34 Cr 20.18 Cr 0.3770 0.00 Cr 0.71 Cr 2.01 Cr -1.46 Cr -3.97 6.38 Cr -0.0274
2024-03-31 51.19 Cr 17.30 Cr 33.89 Cr 0.6621 0.00 Cr 0.56 Cr 3.76 Cr 1.13 Cr 3.11 5.13 Cr 0.0222
2023-03-31 52.66 Cr 20.23 Cr 32.43 Cr 0.6158 0.00 Cr 0.60 Cr 3.10 Cr 0.89 Cr 2.43 4.53 Cr 0.0168
2022-03-31 44.43 Cr 19.80 Cr 24.62 Cr 0.5542 0.00 Cr 0.57 Cr 2.96 Cr 0.63 Cr 1.72 4.53 Cr 0.0141
2021-03-31 36.93 Cr 10.59 Cr 26.35 Cr 0.7133 0.00 Cr 0.67 Cr 3.56 Cr 0.96 Cr 2.64 5.20 Cr 0.0260

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.22 Cr 84.58 Cr 53.83 Cr 30.7549 Cr 33.51 Cr 12.04 Cr 43.48 Cr 19.98 Cr 0.00 Cr 1.60 Cr 0.00 Cr 31.8296 Cr
2024-03-31 0.68 Cr 79.15 Cr 46.93 Cr 32.2184 Cr 27.60 Cr 26.92 Cr 42.52 Cr 12.77 Cr 0.00 Cr 1.66 Cr 0.00 Cr 32.8499 Cr
2023-03-31 0.33 Cr 66.40 Cr 35.32 Cr 31.0840 Cr 14.98 Cr 14.65 Cr 37.24 Cr 6.46 Cr 3.33 Cr 1.66 Cr 0.00 Cr 29.0738 Cr
2022-03-31 0.26 Cr 61.34 Cr 31.14 Cr 30.1982 Cr 14.91 Cr 14.66 Cr 32.26 Cr 7.60 Cr 2.85 Cr 1.66 Cr 0.00 Cr 24.2043 Cr
2021-03-31 0.54 Cr 70.05 Cr 40.47 Cr 29.5711 Cr 19.70 Cr 12.29 Cr 36.23 Cr 8.97 Cr 0.00 Cr 1.92 Cr 0.00 Cr 31.5016 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 13.3286 Cr -11.6073 Cr -2.1864 Cr 1.8595 Cr -0.4651 Cr 0.2195 Cr -11.4691 Cr -1.4637 Cr -2.1864 Cr 0.0000 Cr -0.9659 Cr
2024-03-31 3.7458 Cr -7.9194 Cr 4.5282 Cr -3.9502 Cr 0.3546 Cr 0.6846 Cr -7.6960 Cr 1.1344 Cr 4.5283 Cr 0.0000 Cr -5.2728 Cr
2023-03-31 1.2953 Cr -0.1757 Cr -1.0462 Cr 1.1342 Cr 0.0735 Cr 0.3300 Cr -0.1611 Cr 1.4629 Cr -1.0462 Cr 0.0000 Cr -4.9781 Cr
2022-03-31 4.7509 Cr -0.1661 Cr -4.8669 Cr 4.5939 Cr -0.2821 Cr 0.2565 Cr -0.1570 Cr 1.0745 Cr -2.9749 Cr 0.0000 Cr 3.9676 Cr
2021-03-31 1.9684 Cr -0.8867 Cr -1.2660 Cr 1.1300 Cr -0.1843 Cr 0.5386 Cr -0.8384 Cr 1.5299 Cr 0.7508 Cr 0.0000 Cr -4.0337 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 12.94 Cr 4.33 Cr 8.61 Cr 0.6656 0.28 Cr -0.04 Cr -0.11 1.23 Cr -0.0030
2025-03-31 13.31 Cr 7.85 Cr 5.46 Cr 0.4101 0.80 Cr -1.18 Cr -3.21 2.12 Cr -0.0889
2024-12-31 12.20 Cr 3.24 Cr 8.95 Cr 0.7341 -0.36 Cr -0.85 Cr -2.30 0.76 Cr -0.0695
2024-09-30 14.27 Cr 5.62 Cr 8.66 Cr 0.6064 0.63 Cr 0.13 Cr 0.35 1.79 Cr 0.0089
2024-06-30 13.74 Cr 8.44 Cr 5.29 Cr 0.3853 0.93 Cr 0.30 Cr 0.82 1.72 Cr 0.0217

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.22 Cr 0.00 Cr 0.22 Cr 18.40 Cr 43.48 Cr 62.96 Cr 19.98 Cr 84.58 Cr 53.83 Cr
2024-09-30 1.15 Cr 0.00 Cr 1.15 Cr 20.12 Cr 42.14 Cr 65.23 Cr 20.76 Cr 87.07 Cr 54.43 Cr
2024-03-31 0.68 Cr 0.47 Cr 0.68 Cr 21.95 Cr 42.52 Cr 65.32 Cr 12.77 Cr 79.15 Cr 46.93 Cr
2023-09-30 0.47 Cr 0.00 Cr 0.47 Cr 20.87 Cr 40.23 Cr 62.75 Cr 6.26 Cr 69.63 Cr 38.01 Cr
2023-03-31 0.33 Cr 0.36 Cr 0.33 Cr 21.27 Cr 37.24 Cr 59.37 Cr 6.46 Cr 66.40 Cr 35.32 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 0.31 Cr 0.66 Cr 0.00 Cr 0.00 Cr 0.66 Cr 1.13 Cr 0.47 Cr 0.00 Cr 0.66 Cr
2023-09-30 0.24 Cr 0.24 Cr 0.00 Cr 0.00 Cr 0.24 Cr 0.47 Cr 0.23 Cr 0.00 Cr 0.24 Cr
2023-06-30 0.29 Cr 0.29 Cr 0.00 Cr 0.00 Cr -0.04 Cr 0.29 Cr 0.33 Cr 0.00 Cr 0.29 Cr
2023-03-31 0.14 Cr 0.14 Cr 0.00 Cr 0.00 Cr 0.14 Cr 0.33 Cr 0.19 Cr 0.00 Cr 0.14 Cr
2022-12-31 0.28 Cr 0.28 Cr 0.00 Cr 0.00 Cr 0.28 Cr 0.28 Cr 0.00 Cr 0.00 Cr 0.28 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Specialties

No stocks found in this industry.

Key Executives

Chairman, Chief Executive Officer & MD
Mr. Vijay Kalidas Majrekar B.Com, M.B.A.

Gender: male

Year Born: 1961

Chief Operating Officer
J. Rathod

Gender: Not Specified

Year Born:

Chief Administrative Officer
Ms. Sapna Mhatre

Gender: female

Year Born:

Chief Financial Officer & Whole time Director
Ms. Anuradha Raghunandan Kashikar

Gender: female

Year Born: 1961

Company Secretary & Compliance Officer
Ms. Mahima Bathwal

Gender: female

Year Born:

Executive Director of Sales & Marketing and Whole time Director
Mr. Devraj Thaniya Poojary

Gender: male

Year Born: 1968

FAQs about Centenial Surgical Suture Limited

Who is the CEO of the company?

The CEO is Vijay Kalidas Majrekar.

What is the current market price of the stock?

The current price is ₹110.30.

What is the 52-week price range?

The range is ₹82.15-189.

What is the market capitalization of the company?

The market capitalization is ₹40.24 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -20.17.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Centenial Surgical Suture Limited (ISIN: INE405H01018) is a leading Medical - Specialties in India. With a market capitalization of ₹40.24 crores and an average daily volume of 470 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.